Several studies have reported that FTO has tumour suppressor activity, and its expression is inversely correlated with the progression of ovarian cancer, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and renal cell carcinoma.3 The gene discussed is FTO; the disease is intrahepatic cholangiocarcinoma.